Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	922	553	502	590	532	649
Market Cap Growth	74.97%	10.13%	-14.92%	11.03%	-18.08%	24.93%
Enterprise Value	881	608	600	688	605	749
Last Close Price	71.00	52.83	41.00	52.00	41.00	60.34
PE Ratio	10.10	6.46	40.47	44.94	-	-
PS Ratio	3.11	2.40	2.68	3.69	3.27	4.50
PB Ratio	7.11	6.19	-42.28	-26.35	-8.27	-5.63
P/TBV Ratio	7.13	6.22	-	-	-	-
P/FCF Ratio	9.41	6.90	31.48	139.32	-	-
P/OCF Ratio	9.23	6.74	29.69	77.36	-	-
EV/Sales Ratio	2.88	2.64	3.20	4.31	3.72	5.19
EV/EBITDA Ratio	8.48	8.72	21.78	29.31	154.82	-
EV/EBIT Ratio	8.88	8.93	23.05	30.58	183.33	-
EV/FCF Ratio	8.99	7.58	37.59	162.43	-	-
Debt / Equity Ratio	0.94	1.38	-12.86	-9.03	-3.74	-2.37
Debt / EBITDA Ratio	1.21	1.71	5.05	7.76	41.61	-
Debt / FCF Ratio	1.24	1.54	9.57	47.76	-	-
Asset Turnover	1.08	0.97	0.80	0.63	0.62	0.57
Inventory Turnover	4.69	3.99	4.13	4.18	5.33	6.11
Quick Ratio	5.40	3.93	2.48	1.96	1.22	3.87
Current Ratio	6.32	4.85	3.20	2.34	1.38	4.46
Return on Equity (ROE)	121.15%	218.58%	-	-	-	-
Return on Assets (ROA)	21.88%	17.89%	6.95%	5.56%	0.79%	-5.93%
Return on Invested Capital (ROIC)	106.97%	94.46%	31.17%	44.56%	-	-
Return on Capital Employed (ROCE)	35.70%	29.10%	17.40%	14.30%	4.10%	-11.90%
Earnings Yield	9.91%	15.48%	2.47%	2.23%	-1.41%	-2.56%
FCF Yield	10.62%	14.50%	3.18%	0.72%	-6.73%	-9.74%
Buyback Yield / Dilution	-15.14%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.